The First & Final Frontier: Secrets of Portfolio Selection
Overview
Portfolio selection defines the way the company will perform in the short and long term. This is the most relevant criterion for a company, especially in a generic space, to be successful and profitable. To select a "winning selection" companies spend months of man-hours, use expensive databases and platforms with raw data, and often end up overanalyzing, thereby making this exercise extremely inefficient.
The portfolio management/selection needs to be swift, efficient, and productive, with optimum analysis that would save a lot of time and effort. Important elements of product portfolio development will be covered. The webinar will showcase an effective way to save valuable time and effort and yet provide a way to achieve the desired goals, with an ingenious way of helping Portfolio selection and strategizing your short and long-term goals.
This 2-hours webinar will also provide a demo-cum-workshop using the platform HORIZONS which will form an integral part of this webinar, providing the participants with the latest means to achieve their portfolio development objectives. Using key parameters, algorithms, and a bit of AI, one can now generate the portfolio in seconds, thereby empowering the team and focussing its effort towards actioning the selection process, rather than the selection itself.
This Webinar-cum-Workshop will be held on March 22, 2024, virtually (2.30 pm to 4.30 pm) IST.
Who Should Attend
- Head of Portfolio/Strategy/IP/Licensing/R&D specifically working in Product Selection of the generic pharmaceutical industry,
- MDs/CEOs/Head-BD/Head-R&D engaged in product/portfolio selections and strategy of the mid-size generic pharmaceutical industry
- MDs/CEOs/Head-BD/Head-R&D from Regulatory/Dossier developing organizations engaged in product/portfolio selection and strategy
- MDs/CEOs/Head-BD/Head-R&D from CRO's engaged in product/portfolio selection and strategy
Conference Date
22-03-2024
Avijit Kelkar's Biography
Avijit Kelkar
Co-founder
Aharav Consultants
Dr Avijit Kelkar is a Product / Portfolio and IP strategist, who started Aharav consultants firm in May 2018 after heading Portfolio Strategy and IP with top generic companies such as Dr Reddys, and Sun Pharma. Avijit brings broad range of technical expertise in product selection and strategic risk assessment, bioequivalence in drug development, in combination of his experience in patent and Trademark litigation, patent drafting and invalidation. He is a Post Doctorate in Organic Chemistry, a European Patent practitioner and a GDPR practitioner / consultant for last 4 years and specializes in pharma- GDPR. Avijit is a Co-founder at Aharav consultants, and the main creator conceptualisor of HORIZONS - a portfolio management and strategy platform, which helps companies in product selection and portfolio creation in few hours, thereby saving 99% of time.
Speakers & Panelists
Avijit Kelkar's Biography
Avijit Kelkar
Co-founder
Aharav Consultants
Dr Avijit Kelkar is a Product / Portfolio and IP strategist, who started Aharav consultants firm in May 2018 after heading Portfolio Strategy and IP with top generic companies such as Dr Reddys, and Sun Pharma. Avijit brings broad range of technical expertise in product selection and strategic risk assessment, bioequivalence in drug development, in combination of his experience in patent and Trademark litigation, patent drafting and invalidation. He is a Post Doctorate in Organic Chemistry, a European Patent practitioner and a GDPR practitioner / consultant for last 4 years and specializes in pharma- GDPR. Avijit is a Co-founder at Aharav consultants, and the main creator conceptualisor of HORIZONS - a portfolio management and strategy platform, which helps companies in product selection and portfolio creation in few hours, thereby saving 99% of time.
Co-founder,
Aharav Consultants,
Langley, UK